Wegovy 1.7 MG/0.75 ML pen 0.75ML
Ended Awarded
- Contract number
- SPE2DB26FTLUZ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $49,803
Award facts
- Contract value 100% obligated
- $49,802.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $49,802.50 delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of Wegovy 1.7 mg/0.75 mL pens. The contract utilizes firm fixed pricing with no set-aside designation and is scheduled for completion by October 23, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026.
The SPE2DX prime contract serves as a comprehensive pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications and medical supplies to support military healthcare programs worldwide. As a major pharmaceutical distributor, AmerisourceBergen serves critical federal medical procurement needs for military and veteran healthcare systems through its extensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. The Wegovy delivery order represents a routine pharmaceutical supply fulfillment supporting the Defense Health Agency and other government healthcare systems that maintain access to this diabetes and weight management medication through the broader DLA Medical Supply Chain.
Quick answers
Who was awarded contract SPE2DB26FTLUZ?
SPE2DB26FTLUZ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 22, 2025.
How much is contract SPE2DB26FTLUZ worth?
The government has obligated $49,803 on SPE2DB26FTLUZ.
Is contract SPE2DB26FTLUZ an order under another contract?
Yes. SPE2DB26FTLUZ is a delivery order under SPE2DB25D7056, an indefinite delivery contract.
Was contract SPE2DB26FTLUZ competed?
The extent of competition for SPE2DB26FTLUZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award